May 25 (Reuters) - CSPC Pharmaceutical Group Ltd :
* SAYS HIGHLY SELECTIVE CDK9 INHIBITOR SYHX1903 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Source text for Eikon: Further company coverage:
May 25 (Reuters) - CSPC Pharmaceutical Group Ltd :
* SAYS HIGHLY SELECTIVE CDK9 INHIBITOR SYHX1903 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Source text for Eikon: Further company coverage:
精彩评论